Nodular B-cell aggregates associated with treatment refractory renal transplant rejection resolved by rituximab

American Journal of Transplantation

Volumn 6, Issue 4, 2006, Pages 847-851

  Lehnhardt, A ^a   Mengel, M ^a   Pape, L ^a   Ehrich, J H H ^a   Offner, G ^a   Strehlau, J ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Acute rejection; B cell; CD20; Foxp3; OX40; Rituximab

Indexed keywords

BASILIXIMAB; CD134 ANTIGEN; CD20 ANTIBODY; COMPLEMENT COMPONENT C4D; CYCLOSPORIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; RITUXIMAB; STEROID; THYMOCYTE ANTIBODY; TSUKUBAENOLIDE; CD20 ANTIGEN; CREATININE; GRANZYME B; OX40 LIGAND; RAPAMYCIN;

ARTICLE; B LYMPHOCYTE; CASE REPORT; CELL AGGREGATION; CHILD; CREATININE BLOOD LEVEL; DRUG SUBSTITUTION; GRAFT FAILURE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; MALE; PRIORITY JOURNAL; SINGLE DRUG DOSE; END STAGE RENAL DISEASE; GENE EXPRESSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; LYMPHOCYTIC INFILTRATION; MONONUCLEAR CELL; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; SCHOOL CHILD; TREATMENT REFRACTORY RENAL TRANSPLANT REJECTION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD20; B-LYMPHOCYTES; CHILD; GENE EXPRESSION; GRAFT REJECTION; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LYMPH NODES; MALE; TREATMENT OUTCOME;

EID: 33644771462     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01246.x     Document Type: Article

References (13)

1. Sarwal M Chua MS Kambham N et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling N Engl J Med 2003 349 125 138
2. Strehlau J Cytotoxic T lymphocyte monitoring in steroid-free immunosuppression Pediatr Transplant 2003 7 4 6
3. Strehlau J Pavlakis M Lipman M Shapiro M Strom TB Quantitative detection of immune activation genes as a diagnostic tool in kidney transplantation Proc Natl Acad Sci 1997 94 695 700
4. Meier-Kriesche HU Ojo AO Hanson JA et al. Increased impact of acute rejection on chronic allograft failure in recent era Transplantation 2000 70 1098 1100
5. Kerjaschki D Regele HM Moosberger I et al. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates J Am Soc Nephrol 2004 15 603 612
6. + infiltrates with poorer clinical outcomes in acute cellular rejection of renal allografts Am J Transplant 2005 5 2248 2252
7. Maloney DG Grillo-Lopez AJ White CA et al. IDECC2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed lowgrade non-Hodgkin's lymphoma Blood 1997 90 2188 2195
8. Mounier N Briere J Gisselbrecht C et al. Rituximab plus CHOP (R-CHOP) overcomes bcl-2-associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL) Blood 2003 101 4279 4284 Epub 2003 Feb 4276
9. Watts TH TNF/TNFR family members in costimulation of T cell responses Annu Rev Immunol 2005 23 23 68
10. Rivera A Chen CC Ron N Dougherty JP Ron Y Role of B cells as antigen-presenting cells in vivo revisited: Antigen-specific B cells are essential for T cell expansion in lymph nodes and for systemic T cell responses to low antigen concentrations Int Immunol 2001 13 1583 1593
11. Demirci G Amanullah F Kewalaramani R et al. Critical role of OX40 in CD28 and CD154-independent rejection J Immunol 2004 172 1691 1698
12. Baan CC van der Mast BJ Klepper M et al. Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of FOXP3 in human T cells Transplantation 2005 80 110 117
13. Schachter AD Strehlau J Zurakowski D et al. Increased nuclear factor-kappaB and angiotensinogen gene expression in posttransplant recurrent focal segmental glomerulosclerosis Transplantation 2000 70 1107 1110